申请人:Kyowa Hakko Kirin Co., Ltd.
公开号:EP2543390A1
公开(公告)日:2013-01-09
The present invention provides a pharmaceutical composition comprising a combination of an Hsp 90 family protein inhibitor and at least one compound, the said pharmaceutical composition wherein the Hsp 90 family protein inhibitor is a benozoyl compound represented by formula (I):
[wherein n represents an integer of 1 to 5;
R1 represents substituted or unsubstituted lower alkyl, CONR7R8 (wherein R7 and R8, which may be the same or different, each represent a hydrogen atom, substituted or unsubstituted lower alkyl, or the like), or the like;
R2 represents substituted or unsubstituted aryl, or the like;
R3 and R5, which may be the same or different, each represent a hydrogen atom, substituted or unsubstituted lower alkyl, or the like;
R4 represents a hydrogen atom, hydroxy or halogen; and
R6 represents a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, or the like], or a prodrug thereof; or a-pharmaceutically acceptable salt thereof, and the like.
本发明提供了一种药物组合物,该药物组合物由 Hsp 90 家族蛋白抑制剂和至少一种化合物组合而成,其中 Hsp 90 家族蛋白抑制剂是由式 (I) 表示的苯甲酰化合物:
[其中 n 代表 1 至 5 的整数;
R1 代表取代或未取代的低级烷基、CONR7R8(其中 R7 和 R8 可以相同或不同,各自代表氢原子、取代或未取代的低级烷基或类似物)或类似物;
R2 代表取代或未取代的芳基,或类似物;
R3 和 R5 可以相同或不同,各自代表氢原子、取代或未取代的低级烷基或类似物;
R4 代表氢原子、羟基或卤素;以及
R6 代表氢原子、卤素、取代或未取代的低级烷基或类似物],或其原药;或其药学上可接受的盐,以及类似物。